Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

0

Number of overlapping holdings

0.0%

% of CANC's 48 holdings also in XDNA

nan%

% of XDNA's 3 holdings also in CANC

Overlap by Weight
Sector Drift (CANC minus XDNA)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in CANC
Weight
in XDNA
Overlap

Position Highlights (Non-Overlapping Exposures)
CANC Overweight Relative to XDNA
REVOLUTION MEDICINES, INC. 5.9%
ROCHE HOLDINGS LTD-SPONS ADR 5.2%
ELI LILLY & CO 5.1%
BRIDGEBIO PHARMA, INC. 4.9%
ASTRAZENECA PLC 4.5%
NOVARTIS AG 4.5%
BRISTOL-MYERS SQUIBB CO 4.4%
EXELIXIS INC 4.0%
SUMMIT THERAPEUTICS INC 4.0%
NUVALENT, INC. CLASS A 3.9%
CANC Underweight Relative to XDNA
ARCUS BIOSCIENCES, INC. 0.2%
CELCUITY INC. 0.3%
AUTOLUS THERAPEUTICS PLC SPONSORED A 0.3%
ORIC PHARMACEUTICALS INC 0.4%
RELAY THERAPEUTICS, INC. 0.4%
SYNDAX PHARMACEUTICALS INC 0.4%
ARVINAS, INC. 0.4%
ILLUMINA INC 0.5%
REPLIMUNE GROUP, INC. 0.5%
INCYTE CORP 0.5%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY